AKT1 and cancer: Next, the KEGG enrichment analysis implicated several target genes of GP in cancer-related pathways (hsa05200), PI3K–Akt signaling pathway (hsa04151), estrogen signaling pathway (hsa04915), breast cancer (hsa05224), EGFR tyrosine kinase inhibitor resistance (hsa01521), proteoglycans in cancer (hsa05205), and Ras signaling pathway (hsa04014).